Group One Trading
RCEL icon

Group One Trading’s Avita Medical RCEL Stock Holding History

Group One Trading’s Portfolio RCEL Stock Details RCEL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-500
Closed -$2.65K – 9014
2025
Q2 		$2.65K Sell
500
-4,700
-90% -$34.2K ﹤0.01% 7320
2025
Q1 		$42.3K Buy
5,200
+1,500
+41% +$14K ﹤0.01% 5287
2024
Q4 		$47.4K Hold
3,700
– – ﹤0.01% 5090
2024
Q3 		$39.7K Buy
+3,700
New +$34.8K ﹤0.01% 4798
2024
Q2 		– Sell
-12,400
Closed -$199K – 7351
2024
Q1 		$199K Buy
12,400
+9,400
+313% +$152K ﹤0.01% 3569
2023
Q4 		$41.2K Buy
+3,000
New +$34.4K ﹤0.01% 5215
2023
Q2 		– Sell
-1,200
Closed -$16.8K – 8113
2023
Q1 		$16.8K Buy
+1,200
New +$12.8K ﹤0.01% 5626
2021
Q3 		– Sell
-200
Closed -$4K – 8680
2021
Q2 		$4K Hold
200
– – ﹤0.01% 7832
2021
Q1 		$4K Hold
200
– – ﹤0.01% 7295
2020
Q4 		$4K Sell
200
-300
-60% -$6.58K ﹤0.01% 6106
2020
Q3 		$13K Buy
+500
New +$12.5K ﹤0.01% 5322

Other funds holding RCEL

O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VFT
Vanguard Fiduciary Trust Malvern, Pennsylvania $396B AUM
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
DSCM
Divisadero Street Capital Management Miami, Florida $2.39B AUM 134.55% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Group One Trading's RCEL Position: Q1 2024 in Review

Group One Trading sold out of Avita Medical (RCEL) in Q1 2024, closing a stake of 455 shares — an estimated $7.36K sold.

Group One Trading first reported a position in RCEL in Q3 2020 and held it in 7 quarters. The position peaked at $6.24K in Q4 2023. 82 funds tracked by Wall St. Rank hold RCEL as of Q1 2024.

  • Group One Trading reported no remaining Avita Medical position as of Q1 2024 after selling out during the quarter.
  • Group One Trading sold 455 Avita Medical shares in Q1 2024, an estimated $7.36K.
  • Group One Trading first reported a position in Avita Medical in Q3 2020 and held it in 7 quarters.
  • Group One Trading's Avita Medical position peaked at $6.24K in Q4 2023.
  • 82 funds tracked by Wall St. Rank held Avita Medical as of Q1 2024.

Based on Group One Trading's 13F filing for Q1 2024, filed 10 May 2024.